Zinc Finger 280B regulates sGCa1 and p53 in prostate cancer cells.

Gao S1, Hsieh CL, Zhou J, Shemshedini L
Source: PLoS ONE
Publication Date: (2013)
Issue: 8(11): e78766
Research Area:
Basic Research
Cells used in publication:
Epithelial, prostate (PrEC), human
Species: human
Tissue Origin: prostate
The Zinc Finger (ZNF) 280B protein was identified as an unexpected target of an shRNA designed for sGCa1. Further analysis showed that these two proteins are connected in another way, with 280B up-regulation of sGCa1 expression. Knock-down and over-expression experiments showed that 280B serves pro-growth and pro-survival functions in prostate cancer. Surprisingly however, these pro-cancer functions of 280B are not mediated by sGCa1, which itself has similar functions in prostate cancer, but by down-regulated p53. The p53 protein is a second target of 280B in prostate cancer, but unlike sGCa1, p53 is down-regulated by 280B. 280B induces p53 nuclear export, leading to subsequent proteasomal degradation. The protein responsible for p53 regulation by 280B is Mdm2, the E3 ubiquitin ligase that promotes p53 degradation by inducing its nuclear export. We show here that 280B up-regulates expression of Mdm2 in prostate cancer cells, and this regulation is via the Mdm2 promoter. To demonstrate an in vivo relevance to this interaction, expression studies show that 280B protein levels are up-regulated in prostate cancer and these levels correspond to reduced levels of p53. Thus, by enhancing the expression of Mdm2, the uncharacterized 280B protein provides a novel mechanism of p53 suppression in prostate cancer.